Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A.
Garza
I
I
Mayo Clinic Department of Neurology, Rochester, MN 55905, USA. garza.ivan@mayo.edu
Cutrer
F M
FM
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D051270:Headache Disorders, Primary / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D054969:Primary Dysautonomias / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A